Company intelligence / Profile preview

Ginkgo Pharmaceutical

Huzhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

Ginkgo Pharmaceutical Group is a China-based pharmaceutical company specializing in the research, development, and manufacturing of cardiovascular and cerebrovascular medicines. The company is best known for its expertise in Ginkgo biloba extract-based products, which are utilized for treating cognitive decline and circulatory disorders. Beyond botanical extracts, the firm produces a range of chemical drugs and finished dosage forms including tablets, capsules, and injections. Ginkgo Pharmaceutical operates integrated manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards to serve both domestic and international markets.

Therapeutic areas: CardiovascularNeurology
Modalities: Small moleculeNatural product extract
Industry: Biotech

Beyond the preview

Go deeper on Ginkgo Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ginkgo Pharmaceutical.

Explore the full profile